Abstract
Co-crystal is an attractive alternative and a new class of solid forms because that can be engineered to have desired physicochemical properties. Co-crystals have gained considerable attention from the generic pharmaceutical industry after the USFDA released its finalized guidlines in the year 2018 on the regulatory classification of co-crystals. In this review, we discussed how co-crystals could be explored as a potential alternative solid form for the development of a generic product that meets the legal, regulatory, and bioequivalence requirements. In the contents, we discussed in detail concepts such as the selection of coformers, various ways of making co-crystals, the strategy of characterization to discriminate between co-crystal and salt, polymorphism in co-crystals, the aspects of intellectual property and, finally, the regulatory aspects of co-crystals.
Keywords: Co-crystals, crystal engineering, generic pharmaceuticals, solid oral dosage form, regulatory perspective, polymorphism, solubility.
Recent Advances in Drug Delivery and Formulation
Title:Co-Crystals for Generic Pharmaceuticals: An Outlook on Solid Oral Dosage Formulations
Volume: 15 Issue: 1
Author(s): Maniyam Arun Pandian Rajendran*, Ravikiran Allada and Syed Shahnawaz Sajid
Affiliation:
- Research and Development Department, Novugen Pharma (Malaysia) Sdn. Bhd, Hicom-Glenmarie Industrial Park, Shah Alam 40150, Selangor,Malaysia
Keywords: Co-crystals, crystal engineering, generic pharmaceuticals, solid oral dosage form, regulatory perspective, polymorphism, solubility.
Abstract: Co-crystal is an attractive alternative and a new class of solid forms because that can be engineered to have desired physicochemical properties. Co-crystals have gained considerable attention from the generic pharmaceutical industry after the USFDA released its finalized guidlines in the year 2018 on the regulatory classification of co-crystals. In this review, we discussed how co-crystals could be explored as a potential alternative solid form for the development of a generic product that meets the legal, regulatory, and bioequivalence requirements. In the contents, we discussed in detail concepts such as the selection of coformers, various ways of making co-crystals, the strategy of characterization to discriminate between co-crystal and salt, polymorphism in co-crystals, the aspects of intellectual property and, finally, the regulatory aspects of co-crystals.
Export Options
About this article
Cite this article as:
Rajendran Arun Pandian Maniyam*, Allada Ravikiran and Sajid Shahnawaz Syed , Co-Crystals for Generic Pharmaceuticals: An Outlook on Solid Oral Dosage Formulations, Recent Advances in Drug Delivery and Formulation 2021; 15 (1) . https://dx.doi.org/10.2174/2667387815666210203151209
DOI https://dx.doi.org/10.2174/2667387815666210203151209 |
Print ISSN 2667-3878 |
Publisher Name Bentham Science Publisher |
Online ISSN 2667-3886 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Ascorbic Acid: An Old Player with a Broad Impact on Body Physiology Including Oxidative Stress Suppression and Immunomodulation: A Review
Mini-Reviews in Medicinal Chemistry Organic Antifungal Drugs and Targets of Their Action
Current Topics in Medicinal Chemistry Toxicities of Immunosuppressive Treatment of Autoimmune Neurologic Diseases
Current Neuropharmacology Dendritic Cell Homeostasis in the Regulation of Self-Reactivity
Current Pharmaceutical Design The Effects of Melatonin on the Oxidative Stress and Duration of Atrial Fibrillation after Coronary Artery Bypass Graft Surgery: A Randomized Controlled Trial
Endocrine, Metabolic & Immune Disorders - Drug Targets Patent Annotations
Recent Patents on Anti-Infective Drug Discovery Exploring Pharmacological Significance of Chalcone Scaffold: A Review
Current Medicinal Chemistry The cAMP-Dependent Protein Kinase Pathway as Therapeutic Target – Possibilities and Pitfalls
Current Topics in Medicinal Chemistry Mechanisms Involved in the Genesis of Diabetic Nephropathy
Current Diabetes Reviews A Comprehensive Review on Recent advances in Synthesis & Pharmacotherapeutic potential of Benzothiazoles
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Role of Disproportionality Analysis of Pharmacovigilance Databases in Safety Regulatory Actions: a Systematic Review
Current Drug Safety Biologic Therapy in Psoriasis: Safety Profile
Current Drug Safety Patent Selections
Recent Patents on Biotechnology Anti-Inflammatory Therapy in Uveitis
Recent Patents on Inflammation & Allergy Drug Discovery Nitric Oxide: State of the Art in Drug Design
Current Medicinal Chemistry The Role of Hyphenated Chromatography-Mass Spectrometry Techniques in Exploratory Drug Metabolism and Pharmacokinetics
Current Pharmaceutical Design New Insights into Vitamin D and Autophagy in Inflammatory Bowel Diseases
Current Medicinal Chemistry Drug Metabolizing Enzymes and Transporters mRNA in Peripheral Blood Mononuclear Cells of Healthy Subjects: Biological Variations and Importance of Preanalytical Steps
Current Drug Metabolism Mood Stabilizers, Oxidative Stress and Antioxidative Defense in Euthymia of Bipolar Disorder
CNS & Neurological Disorders - Drug Targets Pharmacological Innovations for Posttraumatic Stress Disorder and Medication- Enhanced Psychotherapy
Current Pharmaceutical Design